English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45065/58241 (77%)
造訪人次 : 2248263      線上人數 : 340
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/52109


    題名: 以藥師執行客製化糖尿病衛教模式對患者健康識能與疾病預後指標之影響
    The Assessment Study: The Effect of Customized Health Education by Pharmacist on Health Literacy and Prognosis Indicator of DM Patients
    作者: 葉爵榮
    Yeh, Jerry-Juezong
    關鍵詞: 糖尿病;藥師;藥事照護;健康識能;糖化血色素;diabetes mellitus;pharmacist;pharmaceutical care;health literacy;HbA1c
    日期: 2015-06-23
    上傳時間: 2018-10-23 16:50:24 (UTC+8)
    摘要: 前言:糖尿病控制穩定不外乎飲食調控、規律運動及常規藥物治療,三者須有計畫的落實於生活中,病人配合度是關鍵,而良好支持體系,才是陪伴病人持續照護計畫執行的原動力,根據國外在糖尿病照護的觀察,社區藥局藥師相較其他醫療照護者能提供多7倍的時間給病人,國內現行醫療環境,多數病人於醫療院所就醫後,仍集中於院區內門診藥局領藥,設置藥事照護門診近似於國外社區藥局藥師所提供之疾病管理服務型態,由藥師專責提供慢性疾病藥事照護,有較充裕時間進行病人用藥評估及提供適切衛教指導,以達個人化諮詢服務之目的。
    目的: 評估門診糖尿病患者接受藥師運用客製化衛教模式執行個案管理輔導,探討介入前後個案對疾病識能影響及年度代謝指標改善程度。
    方法: 本試驗採前瞻性雙世代研究,由新陳代謝科醫師轉介有意願接受藥事照顧的20歲~80歲成年已接受藥物治療之第2型糖尿病人 (排除孕婦、身心障礙病人、精神病人、非使用本國通用語言溝通者),共收案120人,分配為A、B兩組,以三個月為間隔,執行兩階段糖尿病照護能力教育,每次施行教育前進行糖尿病健康識能問卷評量及血液生化值檢測,以觀察病人疾病識能及血糖、血脂等代謝相關生化指標之改變量。第1階段教育內容包含認識糖尿病、藥品資訊提供及指導正確藥品使用,第2階段教育內容包含急症應變處理能力、學習自我血糖監測、基本飲食原則、基本運動原則;適切的藥事照護服務涵蓋雲端藥歷檢核、處方適當性評估、藥品交互作用篩檢、副作用及不良反應預防及發生處置,依需要聯絡開方醫師提供藥品項目或劑量調整建議,前後追蹤至少六個月。A組(60人),於第一次糖尿病識能評量後即開始進行第1階段糖尿病疾病及正確用藥知識教育,三個月後執行第2階段糖尿病自我照護能力知識教育,再間隔三個月執行最後一次糖尿病識能評量後給予糖尿病識能衛教手冊。 B組(60人),第一次只進行糖尿病識能評量,不介入教育,三個月後第二次回診,才開始與A組相同之兩階段糖尿病照護能力教育。
    結果與結論: 本研究已成功運用中文化糖尿病健康識能評量工具連結病生理生化檢驗數據,建立糖尿病衛生教育介入相關成效之量測評估模式,研究結果顯示,糖尿病人在疾病概念及正確用藥教育介入後,對糖尿病認知及健康、藥物資訊閱讀判斷識能均有顯著提升,整體識能分數由70.3%進步至78.4% (p <0.001),進而改變自我照護行為,忘記服藥之情形減少,提高治療配合意願,而在糖尿病自我照護知識教育介入後,更有效提升疾病認知、用藥資訊閱讀判斷識能及糖尿病知識三大健康識能構面,整體識能分數由78.4%進步至86.7% (p <0.001),增加病人在接受藥物治療、健康飲食、適度運動及自我照護行為面向的配合度,並有效改善長期血糖控制指標,六個月追蹤期間,糖化血色素平均達0.5%降幅。

    Background. Diet control, exercise and medication therapy are three main treatment regimens for diabete mellitus. To ensure all three are properly fulfilled, patient compliance behavior is a key factor. Moreover, a good support system is one of the motivational factors for patient to continuously involve in treatment. According to other foreign studies, community pharamacist can provide septuble the time compare to other healthcare provider. In Taiwanese healthcare environment, most of the patient gathered in the pharmacy section after seeing a doctor. Introduction of pharamacuetical outpatient unit provides another way for disease treatment in the foreign countries. Furthermore, the sufficient time will allow pharmacist to provides thorough pharamacuetical care and health education for chronic diseases.
    Purpose. This aim of this study is the effect of pharmacist on disease knowledge and to evaluate the level of disease improvement after pharmacist involvement.
    Method. This study was prospective and double cohort.There were two groups of participants. Each group is consisted of 56 persons and each group received two stages of intervention. Group A was initially evaluated using the health literacy tool and stage 1 intervention was provided.3 month later, patients were firstly evaluate and followed by stage 2 intervention. 6 month later, final evaluation was given. For group B, patients were initially evaluated and no intervention given. 3 months later, patients were firstly evaluated and followed by stage 1 intervention. 6 month later, patients were firstly evaluated and followed by stage 2 intervention. Both groups were evaluated for their health literacy, disease knowledge, and compliance.

    Result and Conclusion. Disease knowledge and health literacy were significantly improved after pharmacist involvement, the overall literacy scale improve from 70.3% to 86.7 (p <0.001). The mean of HbA1c were decrease by 0.5%.
    描述: 碩士
    指導教授-邱瓊萱
    委員-石崇良
    委員-湯澡薰
    資料類型: thesis
    顯示於類別:[醫務管理學系暨研究所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML282檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋